Speakers at Athens Investment Summit
Chief Financial Officer, Pharmathen
Mr. Panagiotis Georgalas is Chief Financial Officer of the Greek drug manufacturer Pharmathen since 2009.
Pharmathen received a €25 million fund for research and development activities from the European Investment Bank as the first Greek business to do so. Pharmathen is listed in the top 110 companies in Europe and the top 7 companies in Greece in the European Business Awards 2014-15 and ranks first Greek company in the 2014 EU Industrial R&D Investment Scoreboard.
Mr. Georgalas has over 15 years of experience in progressively senior roles as finance executive, focusing on M&A, budgeting, tax optimization, implementation of IFRS in diversified business sectors. He has previously served as the International Finance and Administrative Director of Germanos S.A., a leading telecommunication retailer in Greece and Europe, where he was responsible for the company’s mergers and acquisitions’ investment plan worth Euros 170m.
For the period 1994 – 2000, Mr. Georgalas started his career in Intracom SA., multinational manufacturer of telecom products, listed in Athens Stock Exchange. During his most recent position as a CFO/COO of Olympia Development, the holding company of Germanos, he was responsible for the group’s investments worth over € 1 billion as well as the operations of all the Group’s subsidiaries.
Mr. Georgalas holds an MBA from Henley Business School and a BSc in Statistics from the University of Piraeus.
At the Athens Investment Summit, he will speak about the company’s experience with funding from the European Investment Bank and its prospects as an innovative global industry player.